Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179823 | SCV000232137 | likely benign | not specified | 2014-11-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000230834 | SCV000287132 | benign | X-linked myopathy with postural muscle atrophy | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000179823 | SCV000306903 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000179823 | SCV001475112 | benign | not specified | 2020-07-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651048 | SCV001866657 | benign | not provided | 2016-10-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002362923 | SCV002662939 | likely benign | Cardiovascular phenotype | 2019-01-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001651048 | SCV001927571 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000179823 | SCV001955276 | benign | not specified | no assertion criteria provided | clinical testing |